EDITORIAL
Published on 16 Jan 2025
Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling
doi 10.3389/fimmu.2024.1548624
- 309 views
- Frontiers in Immunology
- Vaccines and Molecular Therapeutics
- Research Topics
- Immune studies of SARS-CoV2 and vaccines using preclinical modeling
Immune studies of SARS-CoV2 and vaccines using preclinical modeling
6,561
Total downloads
22k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 14 Oct 2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brain
doi 10.3389/fimmu.2024.1440324
- 1,292 views
ORIGINAL RESEARCH
Published on 30 Aug 2024
Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters
doi 10.3389/fimmu.2024.1430928
- 1,139 views
ORIGINAL RESEARCH
Published on 10 Jul 2024
Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2
doi 10.3389/fimmu.2024.1428711
- 1,091 views
ORIGINAL RESEARCH
Published on 21 Jun 2024
Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency
doi 10.3389/fimmu.2024.1406138
- 2,978 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Jun 2024
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming
doi 10.3389/fimmu.2024.1424374
- 1,060 views
- 1 citation
REVIEW
Published on 26 Feb 2024
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
doi 10.3389/fimmu.2024.1345499
- 1,680 views
- 1 citation
ORIGINAL RESEARCH
Published on 02 Feb 2024
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses
doi 10.3389/fimmu.2024.1292059
- 1,561 views
- 2 citations
ORIGINAL RESEARCH
Published on 22 Jan 2024
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern
doi 10.3389/fimmu.2024.1328905
- 3,591 views
- 11 citations
ORIGINAL RESEARCH
Published on 04 Dec 2023
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant
doi 10.3389/fimmu.2023.1291972
- 1,715 views
- 1 citation
Published in
Frontiers in Immunology
- Vaccines and Molecular Therapeutics
Impact
- 22kTopic views
- 15kArticle views
- 6,561Article downloads